Outcome prediction by extranodal involvement, IPI, R-IPI, and NCCN-IPI in the PET/CT and rituximab era: A Danish-Canadian study of 443 patients with diffuse-large B-cell lymphoma: Extranodal disease in PET/CT staged diffuse large B-cell lymphoma - Tarec Christoffer El-Galaly, Diego Villa, Musa Alzahrani, Jakob Werner Hansen, Laurie H. Sehn, Don Wilson, Peter de Nully Brown, Annika Loft, Victor Iyer, Hans Erik Johnsen, Kerry J. Savage, Joseph M. Connors, Martin Hutchings - Dissemin

Language
Login

Published in

Wiley, American Journal of Hematology, 11(90), p. 1041-1046, 2015

DOI: 10.1002/ajh.24169

Links

ORCID
Wiley | PDF

Tools

Export citation

Search in Google Scholar

Outcome prediction by extranodal involvement, IPI, R-IPI, and NCCN-IPI in the PET/CT and rituximab era: A Danish-Canadian study of 443 patients with diffuse-large B-cell lymphoma: Extranodal disease in PET/CT staged diffuse large B-cell lymphoma

Journal article published in 2015 by Tarec Christoffer El-Galaly

ORCID

, Diego Villa, Musa Alzahrani, Jakob Werner Hansen, Laurie H. Sehn, Don Wilson, Peter de Nully Brown, Annika Loft, Victor Iyer, Hans Erik Johnsen, Kerry J. Savage, Joseph M. Connors, Martin Hutchings

This paper is made freely available by the publisher.

This paper is made freely available by the publisher.

Full text: Download

Green circle

Preprint: archiving allowed

Upload

Orange circle

Postprint: archiving restricted

Upload

Red circle

Published version: archiving forbidden

Policy details

Data provided by

SHERPA/RoMEO